CR6860A - Nuevos compuestos de dibenzoazuleno inhibidores del factor a de necrosis tumoral - Google Patents

Nuevos compuestos de dibenzoazuleno inhibidores del factor a de necrosis tumoral

Info

Publication number
CR6860A
CR6860A CR6860A CR6860A CR6860A CR 6860 A CR6860 A CR 6860A CR 6860 A CR6860 A CR 6860A CR 6860 A CR6860 A CR 6860A CR 6860 A CR6860 A CR 6860A
Authority
CR
Costa Rica
Prior art keywords
tumor necrosis
necrosis factor
compounds
dibenzoazulene
inhibiting
Prior art date
Application number
CR6860A
Other languages
English (en)
Inventor
Mercep Mladen
Mesic Milan
Pesic Dijana
Zupanovic Zeljko
Hrvacic Boska
Original Assignee
Pliva Farmaceutska Indutrija Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Indutrija Dionicko Drustvo filed Critical Pliva Farmaceutska Indutrija Dionicko Drustvo
Publication of CR6860A publication Critical patent/CR6860A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se refiere a los compuestos de dibenzoazuleno representados por la formula I, como asi tambien a sus preparaciones farmaceuticas, para la inhibicion del factor alfa de necrosis tumoral (TNF-a) e interleucina I (IL-1) en mamiferos en todas aquellas enfermedades y condiciones en las que estos mediadores se excretan en forma excesiva. Los compuestos de la presente invencion tambien demuestran una accion analgesica y pueden ser utilizados para aliviar el dolor.
CR6860A 2000-05-17 2002-12-17 Nuevos compuestos de dibenzoazuleno inhibidores del factor a de necrosis tumoral CR6860A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20000310A HRP20000310A2 (en) 2000-05-17 2000-05-17 New dibenzoazulene compounds as tumor necrosis factor inhibitors

Publications (1)

Publication Number Publication Date
CR6860A true CR6860A (es) 2008-06-02

Family

ID=10947110

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6860A CR6860A (es) 2000-05-17 2002-12-17 Nuevos compuestos de dibenzoazuleno inhibidores del factor a de necrosis tumoral

Country Status (36)

Country Link
US (2) US6897211B2 (es)
EP (1) EP1284977B1 (es)
JP (1) JP2003533528A (es)
KR (1) KR100823064B1 (es)
CN (1) CN1194976C (es)
AR (1) AR030562A1 (es)
AT (1) ATE434619T1 (es)
AU (2) AU2001256560B2 (es)
BG (1) BG65967B1 (es)
BR (1) BR0111202A (es)
CA (1) CA2409090C (es)
CR (1) CR6860A (es)
CY (1) CY1109328T1 (es)
CZ (1) CZ301770B6 (es)
DE (1) DE60139070D1 (es)
DK (1) DK1284977T3 (es)
DZ (1) DZ3357A1 (es)
EA (1) EA006069B1 (es)
EE (1) EE200200636A (es)
ES (1) ES2328335T3 (es)
GE (1) GEP20043304B (es)
HR (1) HRP20000310A2 (es)
HU (1) HUP0302295A3 (es)
IL (1) IL152809A0 (es)
IS (1) IS6621A (es)
MA (1) MA27125A1 (es)
MX (1) MXPA02011269A (es)
NO (1) NO20025510L (es)
NZ (1) NZ522553A (es)
PL (1) PL204849B1 (es)
PT (1) PT1284977E (es)
RS (1) RS50893B (es)
SI (1) SI1284977T1 (es)
SK (1) SK17702002A3 (es)
WO (1) WO2001087890A1 (es)
ZA (1) ZA200209180B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020303B8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
DE602005018672D1 (de) 2004-10-27 2010-02-11 Glaxosmithkline Zagreb Konjugate mit entzündungshemmender aktivität
RU2401257C2 (ru) * 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
WO2006075255A2 (en) * 2005-01-13 2006-07-20 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Anti-inflamatory macrolide conjugates
CA2657606A1 (en) 2006-03-08 2007-09-13 Cortria Corporation Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries
US8389482B2 (en) 2007-01-30 2013-03-05 New York University Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
JPS53116385A (en) * 1977-03-19 1978-10-11 Hokuriku Pharmaceutical Pyrazin derivative and method for its production
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
HUP9901613A3 (en) * 1996-04-12 2001-08-28 Janssen Pharmaceutica Nv Substituted tetracyclic fused furanamine derivatives, process for their preparation, use thereof and pharmaceutical compositions containing them
GB9713368D0 (en) * 1997-06-25 1997-08-27 Weston Medical Ltd Flame control
EP0887339A1 (de) * 1997-06-27 1998-12-30 Boehringer Mannheim Gmbh Neue Azulenderivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
ATE434619T1 (de) 2009-07-15
BR0111202A (pt) 2003-04-01
AR030562A1 (es) 2003-08-27
AU5656001A (en) 2001-11-26
BG65967B1 (bg) 2010-07-30
US20050171091A1 (en) 2005-08-04
ES2328335T3 (es) 2009-11-12
DK1284977T3 (da) 2009-09-14
HUP0302295A2 (hu) 2003-10-28
BG107399A (bg) 2003-09-30
ZA200209180B (en) 2003-11-12
CA2409090C (en) 2010-06-29
AU2001256560B2 (en) 2005-10-06
HK1056719A1 (en) 2004-02-27
SI1284977T1 (sl) 2009-10-31
EP1284977A1 (en) 2003-02-26
US6897211B2 (en) 2005-05-24
NZ522553A (en) 2005-04-29
HRP20000310A2 (en) 2002-02-28
GEP20043304B (en) 2004-02-10
SK17702002A3 (sk) 2003-10-07
PT1284977E (pt) 2009-09-09
RS50893B (sr) 2010-08-31
US20030153750A1 (en) 2003-08-14
NO20025510D0 (no) 2002-11-15
CA2409090A1 (en) 2001-11-22
JP2003533528A (ja) 2003-11-11
CY1109328T1 (el) 2012-05-23
IL152809A0 (en) 2003-06-24
IS6621A (is) 2002-11-14
CN1437605A (zh) 2003-08-20
YU84102A (sh) 2006-01-16
CZ301770B6 (cs) 2010-06-16
WO2001087890A1 (en) 2001-11-22
KR20030010625A (ko) 2003-02-05
EP1284977B1 (en) 2009-06-24
EA006069B1 (ru) 2005-08-25
EE200200636A (et) 2004-04-15
DE60139070D1 (de) 2009-08-06
KR100823064B1 (ko) 2008-04-18
PL365054A1 (en) 2004-12-27
EA200201223A1 (ru) 2003-06-26
PL204849B1 (pl) 2010-02-26
NO20025510L (no) 2003-01-14
HUP0302295A3 (en) 2007-03-28
CZ20024090A3 (cs) 2003-05-14
CN1194976C (zh) 2005-03-30
MXPA02011269A (es) 2003-06-06
MA27125A1 (fr) 2005-01-03
DZ3357A1 (fr) 2001-11-22

Similar Documents

Publication Publication Date Title
MX2023002953A (es) Inhibidores de proteína tirosina fosfatasa y métodos para su uso.
GT200500102A (es) Compuestos de aril-o-heteroarilamida ortosustituidos
CL2021000382A1 (es) Compuestos novedosos de sulfonamidaurea
ECSP045476A (es) Tiazolidinonas, su preparación y su uso como medicamentos
CO2021005070A2 (es) Inhibición de la proteasa 30 específica de la ubiquitina (usp30)
UY27511A1 (es) Nuevos agentes andidiabéticos
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
DK1284977T3 (da) Thienodibenzoazulenforbindelser som tumornekrosefaktorhæmmere
GT200500325A (es) Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa
AR078588A1 (es) Combinaciones de un inhibidor de pi3k y un inhibidor de mek
CR10566A (es) Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos
PA8773501A1 (es) Inhibidores de canales de iones
ECSP088283A (es) Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
HN2001000037A (es) Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos
AR047529A1 (es) Compuestos de quinolina sustituidos
CR9507A (es) Sulfonamidas de diarisulfona y sus usos
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
GT200600475A (es) Derivados de pirazina
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
AR131413A1 (es) Inhibidores de la proteína tirosina fosfatasa, composiciones y métodos de uso
AR131414A1 (es) Inhibidores de la proteína tirosina fosfatasa, composiciones y métodos de uso
AR024907A1 (es) Uso de inhibidores de la produccion y/o accion de la il-18 y composiciones farmaceuticas formuladas con dichos inhibidores para el tratamiento demetastasis de tumores.
AR131001A1 (es) Inhibidores de la proteína tirosina fosfatasa, composiciones y métodos de uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)